Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

Published:2024-07 Issue:10450 Volume:404 Page:341-352
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Borchmann Peter,Ferdinandus Justin,Schneider Gundolf,Moccia Alden,Greil Richard,Hertzberg Mark,Schaub Valdete,Hüttmann Andreas,Keil Felix,Dierlamm Judith,Hänel Mathias,Novak Urban,Meissner Julia,Zimmermann Andreas,Mathas Stephan,Zijlstra Josée M,Fosså Alexander,Viardot Andreas,Hertenstein Bernd,Martin Sonja,Giri Pratyush,Scholl Sebastian,Topp Max S,Jung Wolfram,Vucinic Vladan,Beck Hans-Joachim,Kerkhoff Andrea,Unger Benjamin,Rank Andreas,Schroers Roland,zum Büschenfelde Christian Meyer,de Wit Maike,Trautmann-Grill Karolin,Kamper Peter,Molin Daniel,Kreissl Stefanie,Kaul Helen,von Tresckow Bastian,Borchmann Sven,Behringer Karolin,Fuchs Michael,Rosenwald Andreas,Klapper Wolfram,Eich Hans-Theodor,Baues Christian,Zomas Athanasios,Hallek Michael,Dietlein Markus,Kobe Carsten,Diehl Volker

Funder

Takeda Oncology

Publisher

Elsevier BV

Reference32 articles.

1. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP;Bonadonna;Cancer,1975

2. Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute;DeVita;Ann Intern Med,1980

3. Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results;Bonadonna;Ann Intern Med,1986

4. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy;Santoro;J Clin Oncol,1987

5. Hodgkin's lymphoma—the great teacher;Connors;N Engl J Med,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating Novel Agents Into the Clinical Management of Classic Hodgkin Lymphoma;JCO Oncology Practice;2024-09-12

2. Hodgkin lymphoma: 2025 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-09-06

3. Advanced stage classic Hodgkin lymphoma (cHL): biology, clinical features, therapeutic approach, and management at relapse;Leukemia & Lymphoma;2024-09-03

4. The Effect of Diagnostic and Therapeutic Changes on the Survival of Hodgkin’s Lymphoma Patients (1980–2019);Medicina;2024-08-06

5. BrECADD raises the bar in classical Hodgkin lymphoma;Nature Reviews Clinical Oncology;2024-07-22